• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALERE SAN DIEGO, INC. INRATIO PT/INR TEST STRIPS; PROTHROMBIN TIME TEST Back to Search Results
Model Number 100071
Device Problem Low Test Results (2458)
Patient Problems Cellulitis (1768); Erythema (1840); Pain (1994); Swelling (2091); Toxicity (2333)
Event Date 09/07/2014
Event Type  Injury  
Event Description
Caller alleging discrepant low inratio value.Time between inratio value and lab results 13 days.Patient's therapeutic range 2-3.Patient self tester was admitted to the hospital on (b)(6) 2014 3:35 p.M.For cellulitis of right leg and coumadin toxicity.Pain, swelling and redness of leg.No bleeds or bruising noted.Two bags of fresh frozen plasma and two vitamin k pills administered to decrease high inr.Other medications administered were clindamycin and phytonadione.First lab inr was conducted at 4:07 p.M.With a result of 12.7.Second lab inr was conducted at 5:08 p.M.Result 14.22.Exact reference method unknown.Patient discharged at 11:30 p.M.On (b)(6) 2014.Discharge diagnosis cellulitis of the leg and coumadin toxicity.No inr taken upon discharge.Patient in stable condition upon discharge.Patient to follow up with clindamycin (300 mg) at home and follow-up with doctor.
 
Manufacturer Narrative
Investigation pending.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INRATIO PT/INR TEST STRIPS
Type of Device
PROTHROMBIN TIME TEST
Manufacturer (Section D)
ALERE SAN DIEGO, INC.
san diego CA
Manufacturer Contact
ya-ling king
9975 summers ridge rd
san diego, CA 92121
8588052084
MDR Report Key4143981
MDR Text Key4913901
Report Number2027969-2014-00903
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K092987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Not Applicable
Type of Report Initial
Report Date 09/23/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number100071
Device Lot Number341994
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 09/23/2014
Initial Date FDA Received10/02/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
TABLET 1 TAB/MORNING; VERAPAMIL (120 MG TABLET 1X/DAY), 240 MG/12 HRS,; TORSEMIDE (2 MG TABLET, 1 TAB/DAY); ALBUTEROL (2 PUFFS 4X/DAY AS NEEDED); LISINOPRIL (10 MG TABLET, 1 TAB/DAY); BUDESONIDE-FORMOTEROL (2 PUFFS 2X/DAY AS NEEDED); WARFARIN (3 MG (B)(6), 5 MG (B)(6)); DIGOXIN (125 MG TABLET, 1 TAB/DAY); ROSUVASTATIN (10 MG TABLET, 1 TAB/DAY); INRATIO MONITOR, SERIAL # (B)(4)
Patient Outcome(s) Hospitalization; Required Intervention;
-
-